Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect
article
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
Wenshen Xiaozheng Tang treatment decreased endometriosis lesion size and inhibited cell proliferation, likely by reducing angiogenesis via decreased VEGF and HIF-1α expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate the effect of Wenshen Xiaozhng Tang (WXT) on ectopic endometrial growth and on angiogenesis in endometrial implants in a rat model. METHODS: Sprague-Dawley rats with endometriotic implants were randomly treated with low-dose WXT, high-dose WXT, or vehicle (negative control) for 28 days. Cell proliferation and vascular density in the lesions were assessed by immunohistochemistry. The levels of VEGF in peritoneal fluid were determined by ELISA. The mRNA expression of HIF-1α and Flk-1 in the endometriotic lesions was evaluated by real-time PCR. RESULTS: WXT treatment significantly decreased the lesion size and inhibited cell proliferation in the endometriotic lesions. Lowered vascular density and reduced mRNA expression of HIF-1α in the endometriotic lesions, associated with decreased concentration of VEGF in peritoneal fluid, were also observed in WXT-treated rats. CONCLUSIONS: These results suggest that WXT could be effective to suppress the growth of endometriosis, partially through its antiangiogenic activity.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- Advances in Treatment Options of Endometriosis via openalex
- Anti-angiogenic treatment of endometriosis: biochemical aspects. via openalex
- A Western Primer of Chinese Herbal Therapy in Endometriosis and Infertility via openalex
- Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model via openalex
- Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evolution of medical treatment for endometriosis: back to the roots? via openalex
- Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata via openalex
- Immunological regulation of Chinese herb Guizhi Fuling Capsule on rat endometriosis model via openalex
- New trends for the medical treatment of endometriosis via openalex
- Novel Therapies Targeting Endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis via openalex
- Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis via openalex
- W2139576132 via openalex
- W2140543961 via openalex
- W47227538 via openalex
- W2616280937 via openalex
- W1593617111 via openalex
- W1606320450 via openalex
- W1972821205 via openalex
- W1980952928 via openalex
- W1985359220 via openalex
- W1985959551 via openalex
- W2000333628 via openalex
- W2006760151 via openalex
- W2030025004 via openalex
- W2057684012 via openalex
- W2071479387 via openalex
- W2091774189 via openalex
- W2107277218 via openalex
- W2112911107 via openalex
- W2117413404 via openalex
Cited by (7)
- Anti‐Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms 2018
- Ping‐Chong‐Jiang‐Ni Formula Induces Apoptosis and Inhibits Proliferation of Human Ectopic Endometrial Stromal Cells in Endometriosis via the Activation of JNK Signaling Pathway 2017
- Overexpression of Four Joint Box-I Protein (FJXI) in Eutopic Endometrium From Women With Endometriosis 2017
- Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis 2016
- Wenshen Xiaozheng Tang induces apoptosis and inhibits migration of ectopic endometriotic stromal cells 2016
- Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats 2015
- The Complementary and Alternative Medicine for Endometriosis: A Review of Utilization and Mechanism 2014
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:12.052662+00:00
License: CC0
· commercial use OK